REPLIGEN CORP
REPLIGEN CORP
Share · US7599161095 · RGEN · 870980 (XNAS)
Overview Financial Indicators
128,30 USD
1,26 % 1,60 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 20:04

Current Prices from REPLIGEN CORP

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
RGEN
USD
06.06.2025 20:04
128,30 USD
126,70 USD
+1,26 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 8,21 % 0,35 % -17,60 % -14,01 % -11,99 % 9,88 %

Company Profile for REPLIGEN CORP Share

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Company Data

Name REPLIGEN CORP
Company Repligen Corporation
Symbol RGEN
Website https://www.repligen.com
Primary Exchange XNAS NASDAQ
WKN 870980
ISIN US7599161095
Asset Class Share
Sector Healthcare
Industry Medical - Instruments & Supplies
CEO Mr. Olivier Loeillot
Market Capitalization 7 Mrd.
Country United States of America
Currency USD
Employees 1,8 T
Address Building 1, 02453 Waltham
IPO Date 1986-04-29

Ticker Symbols

Name Symbol
Frankfurt RGN.F
NASDAQ RGEN

More Shares

Investors who REPLIGEN CORP hold also have the following shares in their portfolio:
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DEKA MTN A.150
DEKA MTN A.150 Bond
DEXCO INC
DEXCO INC Share
Elevation Oncology, Inc. - Common stock
Elevation Oncology, Inc. - Common stock Share
INTUIT INC
INTUIT INC Share
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Share
RAIF.-NACHHAL.-RENT RVTA
RAIF.-NACHHAL.-RENT RVTA Fund
REGENERON PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS INC Share
TEXAS INSTRUMENTS INC
TEXAS INSTRUMENTS INC Share
V-ID
V-ID Crypto
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025